1. Home
  2. CGON vs INDB Comparison

CGON vs INDB Comparison

Compare CGON & INDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • INDB
  • Stock Information
  • Founded
  • CGON 2010
  • INDB 1907
  • Country
  • CGON United States
  • INDB United States
  • Employees
  • CGON N/A
  • INDB N/A
  • Industry
  • CGON
  • INDB Major Banks
  • Sector
  • CGON
  • INDB Finance
  • Exchange
  • CGON NYSE
  • INDB Nasdaq
  • Market Cap
  • CGON 2.3B
  • INDB 2.7B
  • IPO Year
  • CGON 2024
  • INDB N/A
  • Fundamental
  • Price
  • CGON $29.08
  • INDB $67.04
  • Analyst Decision
  • CGON Strong Buy
  • INDB Strong Buy
  • Analyst Count
  • CGON 10
  • INDB 3
  • Target Price
  • CGON $65.11
  • INDB $73.67
  • AVG Volume (30 Days)
  • CGON 809.2K
  • INDB 263.5K
  • Earning Date
  • CGON 02-02-2025
  • INDB 01-16-2025
  • Dividend Yield
  • CGON N/A
  • INDB 3.40%
  • EPS Growth
  • CGON N/A
  • INDB N/A
  • EPS
  • CGON N/A
  • INDB 4.52
  • Revenue
  • CGON $684,000.00
  • INDB $653,493,000.00
  • Revenue This Year
  • CGON $210.00
  • INDB N/A
  • Revenue Next Year
  • CGON N/A
  • INDB $8.65
  • P/E Ratio
  • CGON N/A
  • INDB $14.83
  • Revenue Growth
  • CGON 258.12
  • INDB N/A
  • 52 Week Low
  • CGON $25.77
  • INDB $45.11
  • 52 Week High
  • CGON $50.23
  • INDB $77.23
  • Technical
  • Relative Strength Index (RSI)
  • CGON 44.86
  • INDB 55.28
  • Support Level
  • CGON $27.70
  • INDB $63.66
  • Resistance Level
  • CGON $29.69
  • INDB $66.32
  • Average True Range (ATR)
  • CGON 1.43
  • INDB 1.91
  • MACD
  • CGON 0.16
  • INDB 0.41
  • Stochastic Oscillator
  • CGON 31.29
  • INDB 87.03

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About INDB Independent Bank Corp.

Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers, and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.

Share on Social Networks: